Citigroup Raises Zymeworks (NYSE:ZYME) Price Target to $22.00

Zymeworks (NYSE:ZYME – Get Free Report) had its target price increased by Citigroup from $19.00 to $22.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 68.97% from the stock’s previous close. ZYME has […]

Leave a Reply

Your email address will not be published.

Previous post Inspired Entertainment (NASDAQ:INSE) Given Buy Rating at BWS Financial
Next post JD.com (NASDAQ:JD) Earns Buy Rating from Analysts at Citigroup